Insiders Simcere Pharmaceutical Group Limited

Equities

2096

HK0000658531

Delayed Hong Kong S.E. Other stock markets 10:31:45 08/05/2024 am IST			5-day change	1st Jan Change
5.67 ^HKD	-0.70%		-0.53%	-15.75%

25/04	Simcere Pharmaceutical’ Profit Down 23% in 2023	MT
10/04	Simcere Pharmaceutical's Cancer Drug Gets Fast Track Designation From US FDA	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Acadia Pharmaceuticals Appoints Kevin Oliver Chief Business Officer	25/23/25	MT
Simcere Pharmaceutical Group Limited Announces Appointment of Members of Remuneration and Appraisal Committee and Nomination Committee	31/23/31	CI
Simcere Pharmaceutical Group Limited Announces Appointment Wang Xi as an Executive Director and the Appointment of Sung Ka Woon as an Independent Non-Executive Director	18/23/18	CI
Simcere Pharmaceutical Group Limited Appoints Mr. Tang Renhong as the Chairman of the Board of Directors and Chief Executive Officer of Simcere Zaiming Pharmaceutical Co., Ltd., with Effect from January 1, 2023	30/22/30	CI
Simcere Pharmaceutical Group Limited Announces Resignation of Mr. Tang Renhong, from the Position of the Co-CEO with Effect from December 31, 2022	30/22/30	CI
Simcere Pharmaceutical Group Limited Announces Executive Changes	09/22/09	CI
Simcere Pharmaceutical Group Limited Appoints Tamas Oravecz as SVP	05/22/05	CI
Simcere Pharmaceutical Group Limited Announces Executive and Committee Changes	31/22/31	CI
Simcere Pharma Appoints Shanghai R&D Head as Co-CEO	26/22/26	MT
Simcere Pharmaceutical Group Limited Announces Appointment of Tang Renhong as Co-Chief Executive Officer	25/22/25	CI
Simcere Pharmaceuticals Announces Appointment of Bijoyesh Mookerjee as Chief Medical Officer, Oncology	08/22/08	CI
Simcere Pharmaceutical Group Limited Announces Resignation of Feng Jie as Joint Company Secretary	30/21/30	CI
Simcere Pharmaceutical Group Limited Announces Resignation of Mr. Zhang Cheng, Effective March 31, 2021	31/21/31	CI
Simcere Pharmaceutical Group. Appoints Zang Jingwu as Chief Scientific Officer	15/13/15	CI
Simcere Pharmaceutical Group Announces Resignation of Chief Scientific Officer Dr. Peng Wang	29/13/29	CI
Simcere Pharmaceutical Group. Announces Resignation of Hong Zhao as Executive Vice President, Effective from April 1, 2013	22/13/22	CI
Simcere Pharmaceutical Group. Appoints Alan Au as Chairman of its Special Committee of Independent Directors	11/13/11	CI
Simcere Pharmaceutical Group. Reports Preliminary Unaudited Consolidated Financial Results for the Fourth Quarter and Full Year Ended December 31, 2012; Appoints Alan Au as an Independent Director and Chairman of the Audit Committee	07/13/07	CI
Simcere Pharmaceutical Group. Announces Resignation of Gary Siu Kwan Sik as Independent Director, Effective from October 11, 2012	12/12/12	CI
Simcere Pharmaceutical Group. Appoints Hongquan Liu, as Chief Executive Officer and Executive Director Effective October 8, 2012	13/12/13	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Simcere Pharmaceutical Group Limited

Equities

2096

HK0000658531

Insiders

Filters